1. Home
  2. SPRO vs SMXT Comparison

SPRO vs SMXT Comparison

Compare SPRO & SMXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRO
  • SMXT
  • Stock Information
  • Founded
  • SPRO 2013
  • SMXT 2008
  • Country
  • SPRO United States
  • SMXT United States
  • Employees
  • SPRO N/A
  • SMXT N/A
  • Industry
  • SPRO Biotechnology: Pharmaceutical Preparations
  • SMXT
  • Sector
  • SPRO Health Care
  • SMXT
  • Exchange
  • SPRO Nasdaq
  • SMXT NYSE
  • Market Cap
  • SPRO 63.0M
  • SMXT 67.0M
  • IPO Year
  • SPRO 2017
  • SMXT 2024
  • Fundamental
  • Price
  • SPRO $0.97
  • SMXT $1.38
  • Analyst Decision
  • SPRO Buy
  • SMXT
  • Analyst Count
  • SPRO 4
  • SMXT 0
  • Target Price
  • SPRO $5.00
  • SMXT N/A
  • AVG Volume (30 Days)
  • SPRO 247.7K
  • SMXT 462.6K
  • Earning Date
  • SPRO 11-14-2024
  • SMXT 03-05-2025
  • Dividend Yield
  • SPRO N/A
  • SMXT N/A
  • EPS Growth
  • SPRO N/A
  • SMXT N/A
  • EPS
  • SPRO 0.06
  • SMXT N/A
  • Revenue
  • SPRO $106,455,000.00
  • SMXT $28,793,764.00
  • Revenue This Year
  • SPRO N/A
  • SMXT N/A
  • Revenue Next Year
  • SPRO N/A
  • SMXT N/A
  • P/E Ratio
  • SPRO $15.29
  • SMXT N/A
  • Revenue Growth
  • SPRO 37.01
  • SMXT N/A
  • 52 Week Low
  • SPRO $0.92
  • SMXT $0.60
  • 52 Week High
  • SPRO $1.89
  • SMXT $15.88
  • Technical
  • Relative Strength Index (RSI)
  • SPRO 39.40
  • SMXT N/A
  • Support Level
  • SPRO $0.92
  • SMXT N/A
  • Resistance Level
  • SPRO $1.13
  • SMXT N/A
  • Average True Range (ATR)
  • SPRO 0.06
  • SMXT 0.00
  • MACD
  • SPRO 0.00
  • SMXT 0.00
  • Stochastic Oscillator
  • SPRO 26.16
  • SMXT 0.00

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About SMXT SOLARMAX TECHNOLOGY INC

SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.

Share on Social Networks: